Eric K. Singhi

707 total citations
26 papers, 471 citations indexed

About

Eric K. Singhi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Eric K. Singhi has authored 26 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Eric K. Singhi's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Advances in Oncology and Radiotherapy (5 papers). Eric K. Singhi is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Advances in Oncology and Radiotherapy (5 papers). Eric K. Singhi collaborates with scholars based in United States, Germany and Peru. Eric K. Singhi's co-authors include Javid J. Moslehi, Edward Gould, Joshua A. Beckman, Arvind K. Pandey, Juan Pablo Arroyo, David G. Harrison, Jonathan D. Brown, T. Alp İkizler, Leora Horn and Aakash Desai and has published in prestigious journals such as Journal of Clinical Oncology, The American Journal of Medicine and Hypertension.

In The Last Decade

Eric K. Singhi

21 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric K. Singhi United States 9 152 134 116 96 61 26 471
Kaoru Kawasaki Japan 16 134 0.9× 115 0.9× 189 1.6× 98 1.0× 46 0.8× 66 814
Mengxia Zhang China 12 148 1.0× 149 1.1× 133 1.1× 58 0.6× 92 1.5× 36 672
Colleen McGuire United States 10 270 1.8× 162 1.2× 138 1.2× 27 0.3× 56 0.9× 16 801
Lorenzo Rossi Switzerland 10 192 1.3× 110 0.8× 90 0.8× 104 1.1× 99 1.6× 30 402
A.V. Lalinga Italy 9 75 0.5× 154 1.1× 102 0.9× 123 1.3× 48 0.8× 16 563
Spyros Batzios Greece 15 147 1.0× 120 0.9× 153 1.3× 27 0.3× 46 0.8× 42 609
Kristina Butler United States 16 136 0.9× 77 0.6× 69 0.6× 41 0.4× 57 0.9× 50 724
Yoland Antill Australia 16 384 2.5× 121 0.9× 81 0.7× 224 2.3× 75 1.2× 46 800
Tarık Salman Türkiye 16 314 2.1× 107 0.8× 84 0.7× 49 0.5× 61 1.0× 67 585
Haitao Xu China 14 88 0.6× 84 0.6× 216 1.9× 63 0.7× 164 2.7× 53 717

Countries citing papers authored by Eric K. Singhi

Since Specialization
Citations

This map shows the geographic impact of Eric K. Singhi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric K. Singhi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric K. Singhi more than expected).

Fields of papers citing papers by Eric K. Singhi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric K. Singhi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric K. Singhi. The network helps show where Eric K. Singhi may publish in the future.

Co-authorship network of co-authors of Eric K. Singhi

This figure shows the co-authorship network connecting the top 25 collaborators of Eric K. Singhi. A scholar is included among the top collaborators of Eric K. Singhi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric K. Singhi. Eric K. Singhi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Singhi, Eric K., Luisa M. Solis, Wei‐Lien Wang, et al.. (2025). Real-world efficacy and safety of tarlatamab in patients with relapsed extensive-stage small cell lung cancer.. Journal of Clinical Oncology. 43(16_suppl). 8088–8088. 1 indexed citations
3.
Sridhar, Arthi, Howard West, & Eric K. Singhi. (2024). Brief Report on Global Clinician Practices in the First-Line Management of Metastatic Non-Small Cell Lung Cancer. Clinical Lung Cancer. 25(7). e286–e294.
4.
Henley, Michael V., et al.. (2024). Decoding clinical trial jargon: helping people understand theefficacy end points used in cancer trials. Future Oncology. 21(1). 11–14.
5.
Singhi, Eric K., et al.. (2024). Caring for Your Heart During Cancer Treatment. JAMA Oncology. 10(10). 1447–1447. 1 indexed citations
6.
Singhi, Eric K., et al.. (2023). OA10.03 Assessing Availability and Demand for Patient-Friendly Resources in Lung Cancer Care: The Patient Perspective. Journal of Thoracic Oncology. 18(11). S65–S66. 1 indexed citations
7.
Singhi, Eric K., Frank E. Mott, Cheuk Hong Leung, et al.. (2023). Clinical outcomes of immunotherapy continued beyond radiographic disease progression in older adult patients with advanced non‑small cell lung cancer. Oncology Letters. 25(6). 262–262. 1 indexed citations
8.
Sridhar, Arthi, et al.. (2023). The Democratization of Hematology-Oncology Medical Education during the COVID-19 Pandemic. Cancer Investigation. 41(6). 548–558. 3 indexed citations
9.
Altan, Mehmet, Eric K. Singhi, Brett W. Carter, et al.. (2022). Clinical Effectiveness and Safety of Anti-PD-(L)1 Therapy Among Older Adults With Advanced Non-Small Cell Lung Cancer. Clinical Lung Cancer. 23(3). 236–243. 9 indexed citations
10.
Singhi, Eric K., et al.. (2020). Medical Hematology/Oncology Fellows’ Perceptions of Online Medical Education During the COVID-19 Pandemic. Journal of Cancer Education. 35(5). 1034–1040. 24 indexed citations
11.
Singhi, Eric K. & Carl M. Gay. (2020). Narrative review of the emerging role of molecular biomarkers in guiding the definitive management of unresectable non-small cell lung cancer. Translational Lung Cancer Research. 9(5). 2051–2058. 3 indexed citations
12.
Hu, Zhihong, et al.. (2020). Mass‐forming neoplastic extramedullary hematopoiesis mimics myeloid sarcoma in a patient with chronic phase chronic myeloid leukemia. International Journal of Laboratory Hematology. 43(3). e135–e137. 1 indexed citations
13.
Feld, Emily, Eric K. Singhi, Sharon Phillips, et al.. (2019). Palliative Care Referrals for Advanced Non–small-cell Lung Cancer (NSCLC): Patient and Provider Attitudes and Practices. Clinical Lung Cancer. 20(3). e291–e298. 32 indexed citations
14.
Singhi, Eric K., Benjamin Li, & Joshua C. Denny. (2018). Simmering Below the Surface: Sweet's Syndrome with Multiple Myeloma. The American Journal of Medicine. 131(9). 1058–1060. 1 indexed citations
15.
Patel, Kashyap, et al.. (2018). Oncology practice transformation helps deliver patient-centered cancer care in a community oncology practice.. PubMed. 24(5 Spec No.). SP147–SP148. 1 indexed citations
16.
Singhi, Eric K., Donald C. Moore, & Alaa Muslimani. (2018). Metastatic Soft Tissue Sarcomas: A Review Of Treatment and New Pharmacotherapies.. PubMed. 43(7). 410–429. 34 indexed citations
17.
Pandey, Arvind K., Eric K. Singhi, Juan Pablo Arroyo, et al.. (2017). Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor–Associated Hypertension and Vascular Disease. Hypertension. 71(2). e1–e8. 237 indexed citations
18.
Mushtaq, Sarah, Eric K. Singhi, & Robert K. Stuart. (2015). “Triple-triple” hit lymphoma. 2(4).
19.
Singhi, Eric K., Sarah Mushtaq, K. Michael Cummings, et al.. (2015). Addressing tobacco use at NCI designated cancer centers: Online resources available for patients.. Journal of Clinical Oncology. 33(15_suppl). e12566–e12566. 1 indexed citations
20.
Nikolova, Yuliya S., Eric K. Singhi, Emily M. Drabant, & Ahmad R. Hariri. (2013). Reward‐related ventral striatum reactivity mediates gender‐specific effects of a galanin remote enhancer haplotype on problem drinking. Genes Brain & Behavior. 12(5). 516–524. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kaoru Kawasaki Breakdown of academic impact, for papers by Mengxia Zhang Breakdown of academic impact, for papers by Colleen McGuire Breakdown of academic impact, for papers by Lorenzo Rossi Breakdown of academic impact, for papers by A.V. Lalinga Breakdown of academic impact, for papers by Spyros Batzios Breakdown of academic impact, for papers by Kristina Butler Breakdown of academic impact, for papers by Yoland Antill Breakdown of academic impact, for papers by Tarık Salman Breakdown of academic impact, for papers by Haitao Xu
Rankless by CCL
2026